Drug survival of anti-tumour necrosis factor alpha therapy in spondyloarthropathies: results from the Spanish emAR II Study

Author(s):: Rosales-Alexander, J.L.; Aznar, J.B.; Perez-Vicente, S.; Magro Checa, C.

Published: 2015
Publication type: Article / Letter to editor

spondyloarthropathiesbiologic therapyanti-tumour necrosis factor alphaswitch

Date issued: 2015-08-31
Language: English
Is part of: Rheumatology (2015), Vol. 54, no. 8, p. 1459-1463
hdl: 1887/95399
doi: 10.1093/rheumatology/kev001